Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES Trial

被引：0
|
作者：
Robert M. Anthenelli
Michael Gaffney
Neal L. Benowitz
Robert West
Thomas McRae
Cristina Russ
David Lawrence
Lisa St. Aubin
Alok Krishen
A. Eden Evins
机构：
[1] University of California,Department of Psychiatry
[2] San Diego,Department of Medicine
[3] Pfizer,undefined
[4] University of California,undefined
[5] University College,undefined
[6] PAREXEL International on behalf of GlaxoSmithKline,undefined
[7] Massachusetts General Hospital and Harvard Medical School,undefined
来源：
Journal of General Internal Medicine | 2019年 / 34卷
关键词：
neuropsychiatric adverse event; smoking cessation medication; varenicline; predictors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：862 / 870
页数：8
相关论文
共 50 条
  • [1] Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES Trial
    Anthenelli, Robert M.
    Gaffney, Michael
    Benowitz, Neal L.
    West, Robert
    McRae, Thomas
    Russ, Cristina
    Lawrence, David
    St Aubin, Lisa
    Krishen, Alok
    Evins, A. Eden
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2019, 34 (06) : 862 - 870
  • [2] Capsule Commentary on Anthenelli et al., Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES Trial
    Satre, Derek D.
    Young-Wolff, Kelly C.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2019, 34 (06) : 999 - 999
  • [3] Capsule Commentary on Anthenelli et al., Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES Trial
    Derek D. Satre
    Kelly C. Young-Wolff
    Journal of General Internal Medicine, 2019, 34 : 999 - 999
  • [4] Sex effects in predictors of smoking abstinence and neuropsychiatric adverse events in the EAGLES trial
    Mckee, Sherry A.
    Lawrence, David E.
    Saccone, Phillip
    Mcrae, Thomas
    Anthenelli, Robert M.
    DRUG AND ALCOHOL DEPENDENCE REPORTS, 2023, 8
  • [5] Psychiatric Comorbidity and Multimorbidity in the EAGLES Trial: Descriptive Correlates and Associations With Neuropsychiatric Adverse Events,Treatment Adherence, and Smoking Cessation
    Correa, John B.
    Lawrence, David
    McKenna, Benjamin S.
    Gaznick, Natassia
    Saccone, Phillip A.
    Dubrava, Sarah
    Doran, Neal
    Anthenelli, Robert M.
    NICOTINE & TOBACCO RESEARCH, 2021, 23 (10) : 1646 - 1655
  • [6] Frequently Reported Adverse Events With Smoking Cessation Medications: Post Hoc Analysis of a Randomized Trial
    Ebbert, Jon
    Jimenez-Ruiz, Carlos
    Dutro, Michael P.
    Fisher, Matt
    Li, Jing
    Hays, J. Taylor
    MAYO CLINIC PROCEEDINGS, 2021, 96 (07) : 1801 - 1811
  • [7] Varenicline, Smoking Cessation, and Neuropsychiatric Adverse Events
    Gibbons, Robert D.
    Mann, J. John
    AMERICAN JOURNAL OF PSYCHIATRY, 2013, 170 (12): : 1460 - 1467
  • [8] Smoking Cessation Pharmacotherapy Efficacy in Comorbid Medical Populations: Secondary Analysis of the Evaluating Adverse Events in a Global Smoking Cessation Study (EAGLES) Randomized Clinical Trial
    Rojewski, Alana M.
    Palmer, Amanda M.
    Baker, Nathaniel L.
    Toll, Benjamin A.
    NICOTINE & TOBACCO RESEARCH, 2024, 26 (01) : 31 - 38
  • [9] Bayesian regularization to predict neuropsychiatric adverse events in smoking cessation with pharmacotherapy
    Van Thi Thanh Truong
    Charles Green
    Claudia Pedroza
    Lu-Yu Hwang
    Suja S. Rajan
    Robert Suchting
    Paul Cinciripini
    Rachel F. Tyndale
    Caryn Lerman
    BMC Medical Research Methodology, 23
  • [10] Bayesian regularization to predict neuropsychiatric adverse events in smoking cessation with pharmacotherapy
    Truong, Van Thi Thanh
    Green, Charles
    Pedroza, Claudia
    Hwang, Lu-Yu
    Rajan, Suja S.
    Suchting, Robert
    Cinciripini, Paul
    Tyndale, Rachel F.
    Lerman, Caryn
    BMC MEDICAL RESEARCH METHODOLOGY, 2023, 23 (01)
12345